
    
      Allogenic platelet rich plasma (PRP) will be collected from blood group AB donors. This
      plasma will be tested for the presence of any chronic infectious blood borne disease.

      Platelet lysate will be then prepared from the tested PRP to be intramuscularly injected in
      patients with PAD
    
  